Search

everythinglearnresearchcommunity

for

Search:↓

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

Higher serum androgens contribute to male pattern baldness.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Physalis peruviana extract is more effective in treating benign prostatic hyperplasia in rats than finasteride and terazosine.

There is no link between hair loss and prostate enlargement.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Hair loss can be an early sign of prostate enlargement.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

St. John's Wort may reduce the effectiveness of finasteride by increasing its breakdown in the body.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.

Ivermectin 1% cream effectively reduces visible and invisible symptoms of rosacea.

The document concludes that better training and education are needed for proper cancer screening and criticizes the GMC's inaction as harmful to clinical ethics in the UK.

Long-term diabetes is linked to lower prostate cancer risk.

Pumpkin seed oil may improve prostate health, bladder control, and hair growth in men.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Early hair loss may indicate future prostate issues.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Shorter PSADT after prostate surgery is linked to higher risk of death.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.